Stay updated on Vaccination With Flt3L, Radiation, and Poly-ICLC Clinical Trial
Sign up to get notified when there's something new on the Vaccination With Flt3L, Radiation, and Poly-ICLC Clinical Trial page.

Latest updates to the Vaccination With Flt3L, Radiation, and Poly-ICLC Clinical Trial page
- Check5 days agoChange DetectedThe clinical trial record for the Flt3L, radiation, Poly-ICLC, and pembrolizumab study is now displayed, with details on its completed status, study plan, participants, and outcomes. It also includes an informed consent form and related study information.SummaryDifference53%

- Check13 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check20 days agoChange DetectedA site-wide NIH notice says agencies are transitioning from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs about the change.SummaryDifference1%

- Check26 days agoChange DetectedThe error page’s footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check54 days agoChange DetectedThe study page now displays a 403 Forbidden error, blocking access to the NCT03789097 record and replacing study content with a permissions message. This reflects an access issue rather than a modification to the study data.SummaryDifference19%

Stay in the know with updates to Vaccination With Flt3L, Radiation, and Poly-ICLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vaccination With Flt3L, Radiation, and Poly-ICLC Clinical Trial page.